A detailed history of Macquarie Group LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 956,299 shares of TMDX stock, worth $159 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
956,299
Previous 1,297,719 26.31%
Holding current value
$159 Million
Previous $96 Million 50.11%
% of portfolio
0.17%
Previous 0.11%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$72.62 - $150.62 $24.8 Million - $51.4 Million
-341,420 Reduced 26.31%
956,299 $144 Million
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $16.2 Million - $20.5 Million
-228,100 Reduced 14.95%
1,297,719 $96 Million
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $6.8 Million - $15 Million
-185,032 Reduced 10.82%
1,525,819 $120 Million
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $892,146 - $1.6 Million
16,685 Added 0.98%
1,710,851 $93.7 Million
Q2 2023

Aug 14, 2023

SELL
$66.23 - $88.73 $3.39 Million - $4.54 Million
-51,191 Reduced 2.93%
1,694,166 $142 Million
Q1 2023

May 15, 2023

SELL
$53.63 - $82.33 $10.8 Million - $16.6 Million
-202,115 Reduced 10.38%
1,745,357 $132 Million
Q4 2022

Feb 21, 2023

BUY
$39.08 - $64.29 $7.71 Million - $12.7 Million
197,273 Added 11.27%
1,947,472 $120 Million
Q3 2022

Nov 14, 2022

SELL
$31.56 - $55.75 $2.36 Million - $4.16 Million
-74,636 Reduced 4.09%
1,750,199 $73.1 Million
Q2 2022

Aug 15, 2022

SELL
$20.56 - $32.15 $5.18 Million - $8.1 Million
-251,901 Reduced 12.13%
1,824,835 $57.4 Million
Q1 2022

May 16, 2022

BUY
$12.58 - $26.94 $5.35 Million - $11.5 Million
425,450 Added 25.76%
2,076,736 $55.9 Million
Q4 2021

Feb 11, 2022

BUY
$19.16 - $32.68 $518,661 - $884,647
27,070 Added 1.67%
1,651,286 $31.6 Million
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $2.72 Million - $3.63 Million
105,095 Added 6.92%
1,624,216 $53.7 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $11.9 Million - $22.1 Million
550,627 Added 56.85%
1,519,121 $50.4 Million
Q1 2021

May 14, 2021

BUY
$17.75 - $47.82 $131,722 - $354,872
7,421 Added 0.77%
968,494 $40.2 Million
Q4 2020

Feb 16, 2021

BUY
$11.91 - $19.9 $2.58 Million - $4.3 Million
216,212 Added 29.03%
961,073 $19.1 Million
Q3 2020

Nov 13, 2020

BUY
$13.78 - $18.84 $4.98 Million - $6.8 Million
361,110 Added 94.1%
744,861 $10.3 Million
Q2 2020

Aug 11, 2020

BUY
$11.66 - $18.26 $4.47 Million - $7.01 Million
383,751 New
383,751 $6.88 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $5.28B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.